Pregnant women with erythema migrans and isolation of borreliae from blood: Course and outcome after treatment with ceftriaxone

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 4, 2011, Pages 446-448

  Maraspin, Vera ^a   Ružić Sabljić, Eva ^b   Pleterski Rigler, Dušica ^a   Strle, Franc ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Blood cultures; Ceftriaxone; Erythema migrans; Outcome; Pregnancy

Indexed keywords

BACTERIAL ANTIGEN; CEFTRIAXONE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OSPC ANTIGEN; UNCLASSIFIED DRUG; VISE ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD ANALYSIS; BORRELIA; BORRELIA AFZELII; BORRELIA GARINII; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ELECTROCARDIOGRAPHY; ERYTHEMA CHRONICUM MIGRANS; ETHNIC GROUP; FEMALE; HUMAN; IMMUNOASSAY; LABORATORY TEST; MICROBIOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROLOGY; SPIROCHETE INFECTION; SPIROCHETEMIA; STRUCTURED QUESTIONNAIRE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTI-BACTERIAL AGENTS; BLOOD; BORRELIA BURGDORFERI GROUP; CEFTRIAXONE; EUROPE; FEMALE; GLOSSITIS, BENIGN MIGRATORY; HUMANS; INFUSIONS, INTRAVENOUS; LYME DISEASE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME;

EID: 82555166992     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.07.017     Document Type: Article

References (18)

1. Arnez M., Ruzic-Sabljic E., Ahcan J., Radsel-Medvescek A., Pleterski-Rigler D., Strle F. Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. Pediatr. Infect. Dis. J. 2001, 20:251-255.
2. Centers for Disease Control and Prevention (CDC) Case definitions for infectious conditions under public health surveillance: Lyme disease (revised 9/96). MMWR Morb. Mortal. Wkly. Rep. 1997, 46:20-21.
3. Liveris D., Wang G., Girao G., Byrne D.W., Nowakowski J., McKenna D., Nadelman R., Wormser G.P., Schwartz I. Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J. Clin. Microbiol. 2002, 40:1249-1253.
4. MacDonald A.B., Benach J.L., Burgdorfer W. Stillbirth following maternal Lyme disease. N. Y. State J. Med. 1987, 87:615-616.
5. Maraspin V., Cimperman J., Lotric-Furlan S., Pleterski-Rigler D., Strle F. Treatment of erythema migrans in pregnancy. Clin. Infect. Dis. 1996, 22:788-793.
6. Maraspin V., Cimperman J., Lotric-Furlan S., Pleterski-Rigler D., Strle F. Erythema migrans in pregnancy. Wien. Klin. Wochenschr. 1999, 111:933-940.
7. Maraspin V., Ruzic-Sabljic E., Cimperman J., Lotric-Furlan S., Jurca T., Picken R.N., Strle F. Isolation of Borrelia burgdorferi sensu lato from blood of patients with erythema migrans. Infection 2001, 29:65-70.
8. Markowitz L.E., Steere A.C., Benach J.L., Slade J.D., Broome C.V. Lyme disease during pregnancy. JAMA 1986, 255:3394-3396.
9. Ruzic-Sabljic E., Arnez M., Lotric-Furlan S., Maraspin V., Cimperman J., Strle F. Genotypic and phenotypic characterisation of Borrelia burgdorferi sensu lato strains isolated from human blood. J. Med. Microbiol. 2001, 50:896-901.
10. Ruzic-Sabljic E., Maraspin V., Lotric-Furlan S., Jurca T., Logar M., Pikelj A., Strle F. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien. Klin. Wochenschr. 2002, 114:544-550.
11. Schlesinger P.A., Duray P.H., Burke S.A., Steere A.C., Stillman M.T. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann. Intern. Med. 1985, 103:67-68.
12. Stanek G., Fingerle V., Hunfeld K.P., Jaulhac B., Kaiser R., Krause A., Kristoferitsch W., O'Connell S., Ornstein K., Strle F., Gray J. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin. Microbiol. Infect. 2011, 17:69-79.
13. Stanek G., Strle F. Lyme borreliosis. Lancet 2003, 362:1639-1647.
14. Steere A.C. Lyme disease. N. Engl. J. Med. 2001, 345:115-125.
15. Strle F., Stanek G. Clinical manifestations and diagnosis of Lyme borreliosis. Curr. Probl. Dermatol. 2009, 37:51-110.
16. Taber L.H., Feigin R.D. Spirochetal infections. Pediatr. Clin. North Am. 1979, 26:377-413.
17. Weber K., Bratzke H.J., Neubert U., Wilske B., Duray P.H. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr. Infect. Dis. J. 1988, 7:286-289.
18. Wormser G.P., McKenna D., Carlin J., Nadelman R.B., Cavaliere L.F., Holmgren D., Byrne D.W., Nowakowski J. Hematogenous dissemination in early Lyme disease. Ann. Intern. Med. 2005, 142:751-755.